Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefdinir vs Azithromycin in Pediatric Acute Otitis Media
NCT00645112Phase 4Completed
- Sponsor
- Abbott Laboratories
- Start
- Nov 2003
- Primary completion
- Jan 2004
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of cefdinir in acute otitis media (AOM) (2 arms), sponsored by Abbott Laboratories. Primary endpoint: Clinical cure rate at Evaluation 2 at 9 days. Started Nov 2003; status: completed.
02
Drugs
cefdinir
03
Conditions
acute otitis media (AOM)
Beyond the preview
Go deeper on NCT00645112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645112.